EUVIMEDEUVIMED entdecken
Open Access

Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn’s disease

David L Suskind iD, Lucas R Hoffman iD, Dale Lee, Adrian J Verster, Hengqi Betty Zheng, Kendra Francis, Mason Nuding, Jairam Vanamala, Ghassan Wahbeh, Hayley Purcell, Danijel Djukovic iD, Daniel Raftery iD und 1 weitere

Inflammatory Bowel Diseases · 2026

DOI: 10.1093/ibd/izag095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von David L Suskind und 12 weiteren Autor:innen. Beteiligte Einrichtung: Inflammatory Bowel Disease Center, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Seattle Children's Ho…. Hauptthemen laut MEDLINE: Crohn Disease, Enteral Nutrition, Metabolome. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Richards Family Foundation, NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

For children with Crohn’s disease (CD), dietary therapy with exclusive enteral nutrition (EEN) is effective in achieving clinical and biochemical remission. We investigated changes in metabolites in multiple clinical sample types from children with CD following a whole foods–blended (“reverse-engineered”) EEN formula and defined associations between these changes and remission.

Methods

Stool, urine, serum, and plasma from a prospective study of newly diagnosed pediatric patients with CD enrolled in a 4-week trial of reverse-engineered exclusive enteral nutrition (RE-EEN) were analyzed using mass spectrometry targeting aqueous metabolites, bile acids, and short-chain fatty acids. Principal component analysis, mixed-effects models, and exploratory multivariate approaches including random forest and partial least-squares discriminant analysis were used to identify patterns associated with diet and metabolite abundances.

Results

Fecal, urine, serum, and plasma metabolomes changed significantly during RE-EEN treatment from baseline. These global changes were largely driven by increases in amino acids and related metabolites and decreases in different amino acids and metabolites reflecting carbohydrate and purine metabolism, in all sample types. While global bile acid profiles changed with the RE-EEN diet, no changes in specific bile acid levels reached significance, and no changes were found in short-chain fatty acid concentrations.

Conclusion

Metabolomic profiles for pediatric patients with CD changed broadly during RE-EEN, indicating that this therapy may modulate key systemic and gut-associated metabolic processes. The findings further suggest that the gut metabolic processes influenced by RE-EEN, and that contribute to clinical improvement, may differ from those impacted by commercial EEN diets. Further research is crucial to validate these findings, uncover causal relationships, and optimize dietary protocols to enhance therapeutic outcomes in CD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseEnteral NutritionMetabolomeHumansFemaleMaleChildProspective StudiesAdolescentBile Acids and SaltsFood, FormulatedFecesPrognosisFollow-Up StudiesMetabolomics

Stichwörter der Autor:innen

Crohn’s diseaseexclusive enteral nutritionmetabolomicsnutrition

Substanzen

Bile Acids and Salts

Autor:innen und Institutionen

  • Inflammatory Bowel Disease Center, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Seattle Children's Hospital, Seattle, WA 98105, United States.
  • Department of Microbiology, University of Washington, Seattle, WA 98195, United States.
  • Pythia Informatics, Ottawa, ON K1S 0S7, Canada.
  • Northwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98109, United States.

ORCID-Profile: David L Suskind, Lucas R Hoffman, Danijel Djukovic, Daniel Raftery, Hillary S Hayden

Förderung

  • Richards Family Foundation
  • NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Suskind, D. L., Hoffman, L. R., Lee, D., Verster, A. J., Zheng, H. B., Francis, K., Nuding, M., Vanamala, J., Wahbeh, G., Purcell, H., Djukovic, D., Raftery, D., & Hayden, H. S. (2026). Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn’s disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag095

Vancouver

Suskind DL, Hoffman LR, Lee D, Verster AJ, Zheng HB, Francis K, et al. Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn’s disease. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izag095

BibTeX
@article{Suskind2026,
  author = {Suskind, David L and Hoffman, Lucas R and Lee, Dale and Verster, Adrian J and Zheng, Hengqi Betty and Francis, Kendra and Nuding, Mason and Vanamala, Jairam and Wahbeh, Ghassan and Purcell, Hayley and Djukovic, Danijel and Raftery, Daniel and Hayden, Hillary S},
  title = {Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn’s disease},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  doi = {10.1093/ibd/izag095}
}
Kostenlos starten →